Skip to main content
Journal cover image

Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: Their prevalence and clinical relevance

Publication ,  Journal Article
Mendenhall, CL; Seeff, L; Diehl, AM; Ghosn, SJ; French, SW; Gartside, PS; Rouster, SD; Buskell‐Bales, Z; Grossman, CJ; Roselle, GA; Weesner, RE ...
Published in: Hepatology
January 1, 1991

Patients with overt alcoholic liver disease who had participated in a multicenter therapeutic trial and subgroups of controls (i.e., alcoholic patients without liver disease and patients with neither alcoholism nor liver disease) were tested for hepatitis B virus and hepatitis C virus antibodies to determine the prevalence of these antibodies and any clinical association in the progression and outcome of alcoholic liver disease. Antibodies to hepatitis B (anti–HBs and/or anti‐HBc) were found in 29.2% of patients with alcoholic liver disease, in 26.1% of hospitalized alcoholic patients without liver disease and in 24.2% of hospitalized nonalcoholic patients without liver disease; frequencies were not significantly different from one another. HBsAg was not evaluated because HBsAg+ patients had been excluded from the original trial. The presence of these antibody markers correlated with ethnic origin of and immunoglobulin levels in the patients. In contrast, antibody to hepatitis C, as detected by enzyme immunoassay, was positive in 27.1%, 4.8% and 3.0% of the three groups, respectively, the first differing significantly from the other two. Antibody to hepatitis C virus positivity correlated significantly with clinical severity of the disease and with the presence of histological features that imply chronic viral infection (periportal inflammation, cirrhosis), despite the fact that the supplementary assay for antibody to hepatitis C virus, using recombinant immunoblot assay, reduced the positive rate by 79%. Although the presence of hepatitis B antibodies did not correlate with patient survival, some categories of patients with antibody to hepatitis C virus did; the survival of those with antibody to hepatitis C virus and recombinant immunoblot assay reactivity was 67%; for those with antibody to hepatitis C virus positivity but recombinant immunoblot assay negativity the survival was 29% (p < 0.01). The reason for the poor prognosis for those with antibody to hepatitis C virus positivity and recombinant immunoblot assay negativity is not clear, although some theories are offered. (HEPATOLOGY 1991;14:581–589.) Copyright © 1991 American Association for the Study of Liver Diseases

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Hepatology

DOI

EISSN

1527-3350

ISSN

0270-9139

Publication Date

January 1, 1991

Volume

14

Issue

4

Start / End Page

581 / 589

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mendenhall, C. L., Seeff, L., Diehl, A. M., Ghosn, S. J., French, S. W., Gartside, P. S., … Rabin, L. (1991). Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: Their prevalence and clinical relevance. Hepatology, 14(4), 581–589. https://doi.org/10.1002/hep.1840140402
Mendenhall, C. L., L. Seeff, A. M. Diehl, S. J. Ghosn, S. W. French, P. S. Gartside, S. D. Rouster, et al. “Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: Their prevalence and clinical relevance.” Hepatology 14, no. 4 (January 1, 1991): 581–89. https://doi.org/10.1002/hep.1840140402.
Mendenhall CL, Seeff L, Diehl AM, Ghosn SJ, French SW, Gartside PS, et al. Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: Their prevalence and clinical relevance. Hepatology. 1991 Jan 1;14(4):581–9.
Mendenhall, C. L., et al. “Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: Their prevalence and clinical relevance.” Hepatology, vol. 14, no. 4, Jan. 1991, pp. 581–89. Scopus, doi:10.1002/hep.1840140402.
Mendenhall CL, Seeff L, Diehl AM, Ghosn SJ, French SW, Gartside PS, Rouster SD, Buskell‐Bales Z, Grossman CJ, Roselle GA, Weesner RE, Garcia‐Pont P, Goldberg SJ, Kiernan TW, Tamburro CH, Zetterman R, Chedid A, Chen T, Rabin L. Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: Their prevalence and clinical relevance. Hepatology. 1991 Jan 1;14(4):581–589.
Journal cover image

Published In

Hepatology

DOI

EISSN

1527-3350

ISSN

0270-9139

Publication Date

January 1, 1991

Volume

14

Issue

4

Start / End Page

581 / 589

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics